Insights

News Show all

News

Kiel Lights Up Purple for World IBD Day 2026

đź’ś On World IBD Day 2026, the Institute of Clinical Molecular Biology (IKMB) at UniKiel and the UKSH, together with the Cluster of Excellence “Precision Medicine in Chronic Inflammation”, are raising awareness for inflammatory bowel diseases (IBD).

…read more

Our mission

Patterns of gut microbiome dysbiosis in patients with inflammatory bowel diseases are inconsistent among published studies, probably owing to the heterogeneity of the disease and given the fact that patients enrolled in research studies are often treated and in remission. Therefore, more microbiome studies in “early” (incident) patients that are treatment-naïve and in high-risk individuals are needed. In addition, the microbiome field has to move from association to rather mechanistic studies in order to understand the actual functions and to also prove the associations that serve as hypotheses.

Institute of Clinical Molecular Biology
Kiel University
Rosalind-Franklin-Str. 12
24105 Kiel

Spokesperson
Prof. Dr. rer. nat. Andre Franke
Fon: +49 (0)431-500-15112
a.franke@ikmb-uni-kiel.de

Coordination
Dr. oec. troph. Jana Koop
Fon: +49 (0)431 500-15114
j.koop@ikmb.uni-kiel.de

Participating Institutes